Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Sophie Dumoucel
Observed names:
DUMOUCEL, Sophie,
S. Dumoucel
Observed institutions:
Inserm,
Institut Gustave Roussy,
Centre Hospitalier Universitaire Sainte-Justine,
Centre Hospitalier Universitaire de Nantes,
Hôpital Mère-Enfant,
Université de Nantes,
Université de Montréal,
Institut Curie,
Nantes Université
show all 9
OpenAlex ID:
A5000701606
NUT carcinoma in children and adults: A multicenter retrospective study
2017
·
Lauriane Lemelle
, Gaëlle Pierron
, et al.
·
Pediatric Blood & Cancer
·
88
Zoledronic Acid as a New Adjuvant Therapeutic Strategy for Ewing's Sarcoma Patients
2010
·
Guillaume A. Odri
, Sophie Dumoucel
, et al.
·
Cancer Research
·
84
Malformations, genetic abnormalities, and wilms tumor
2013
·
S. Dumoucel
, M. Gauthier‐Villars
, et al.
·
Pediatric Blood & Cancer
·
78
Molecular Profiling of Hard-to-Treat Childhood and Adolescent Cancers
2019
·
Fida Khater
, Stephanie Vairy
, et al.
·
JAMA Network Open
·
61
PDF
Impact of oncopediatric dosing regimen of zoledronic acid on bone growth: Preclinical studies and case report of an osteosarcoma pediatric patient
2011
·
Séverine Battaglia
, Sophie Dumoucel
, et al.
·
Journal of Bone and Mineral Research
·
39
Conservative management of a perianal rhabdomyosarcoma in a 2-year old child by Papillon’s technique
2015
·
Charlotte Demoor-Goldschmidt
, Sophie Dumoucel
, et al.
·
Radiation Oncology
·
4
PDF
Évaluation de la gastrostomie précoce dans la prise en charge des tumeurs osseuses primitives malignes de l’enfant. Expérience du groupe Grand Ouest Cancer de l’Enfant (GOCE) sur 10 ans
2017
·
C. Henry
, S. Dumoucel
, et al.
·
Revue d Oncologie Hématologie Pédiatrique
·
2
Impact of onco-pediatric dosing regimen of zoledronic acid on bone growth: Preclinical studies and case report of an osteosarcoma pediatric patient
2011
·
S. Battaglia
, S. Dumoucel
, et al.
·
Bone
·
2
Supplementary Table 1, Figures 1-3 from Zoledronic Acid as a New Adjuvant Therapeutic Strategy for Ewing's Sarcoma Patients
2023
·
Guillaume A. Odri
, Sophie Dumoucel
, et al.
Data from Zoledronic Acid as a New Adjuvant Therapeutic Strategy for Ewing's Sarcoma Patients
2023
·
Guillaume A. Odri
, Sophie Dumoucel
, et al.
Abstract 4885: Identification of actionable targets for refractory/relapsed childhood cancer leading to personalized targeted therapy (TRICEPS Study)
2017
·
Fida Khater
, Stephanie Vairy
, et al.
·
Cancer Research
Résultats et analyse de l’enregistrement des patients atteints d’une tumeur osseuse primitive dans le réseau national RESOS en 2015
2016
·
Francois Gouin
, de Pinieux Gonzague
, et al.
·
Revue de Chirurgie Orthopédique et Traumatologique
Abstract A41: TRICEPS: A feasibility study of personalized targeted therapy in relapsed/refractory childhood cancers
2016
·
Sylvie Langlois
, Jasmine Healy
, et al.
·
Cancer Research
Tr-16 * Personalized Targeted Therapy in Refractory or Relapsed Cancer in Childhood (triceps Study)
2015
·
S. Dumoucel
, M. Duval
, et al.
·
Neuro-Oncology
7.o.08 Zoledronic Acid as New Adjuvant Therapeutic Agent for Ewing’s Sarcoma
2010
·
Guillaume Odri
, François Lamoureux
, et al.
·
Orthopaedic Proceedings
Zoledronic acid as new adjuvant therapeutic agent for Ewing's sarcoma
2010
·
Guillaume Odri
, Sophie Dumoucel
, et al.
·
Bone
Zoledronic acid as new adjuvant therapeutic agent for Ewing's sarcoma
2009
·
G.A. Odri
, F. Lamoureux
, et al.
·
Bone
Show more works
View as search
Works count:
18
Citation count:
358
H-index:
5
I10-index:
5
Year
Topic
Type